NCT03110861View on ClinicalTrials.gov

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

November 6, 2019

Study Completion Date

July 12, 2024

Conditions
Congenital Heart DefectPulmonary Valve; Insufficiency, CongenitalPulmonary Valve Stenosis
Interventions
DEVICE

Pulsta® Transcatheter Pulmonary Valve (TPV) Replacement

Pulsta® Transcatheter Pulmonary Valve Replacement

Trial Locations (5)

14754

Sejong General Hospital, Bucheon-si

03080

Seoul National University Hospital, Seoul

06351

Samsung Medical Center, Seoul

05505

Asan Medical Center, Seoul

03722

Severance Hospital, Seoul

All Listed Sponsors
lead

Taewoong Medical Co., Ltd.

INDUSTRY

NCT03110861 - Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study | Biotech Hunter | Biotech Hunter